WDR43 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.763600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.016000E-01
Normal-vs-Stage2
9.584600E-01
Normal-vs-Stage3
2.374400E-01
Normal-vs-Stage4
9.061600E-02
Stage1-vs-Stage2
6.206800E-01
Stage1-vs-Stage3
2.378200E-01
Stage1-vs-Stage4
1.963830E-02
Stage2-vs-Stage3
9.865600E-02
Stage2-vs-Stage4
1.453900E-02
Stage3-vs-Stage4
1.140340E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.861200E-01
Normal-vs-AfricanAmerican
7.744000E-01
Normal-vs-Asian
4.272200E-01
Caucasian-vs-AfricanAmerican
5.282400E-01
Caucasian-vs-Asian
7.813700E-02
AfricanAmerican-vs-Asian
3.141000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.444200E-01
Normal-vs-Female
9.739200E-01
Male-vs-Female
6.889800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.020000E-01
Normal-vs-Age(41-60Yrs)
7.731200E-01
Normal-vs-Age(61-80Yrs)
8.289000E-01
Normal-vs-Age(81-100Yrs)
8.105200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.934200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.215600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.006000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.186100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.589000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.116600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.186600E-01
Normal-vs-Daily Drinker
7.765600E-01
Normal-vs-Weekly Drinker
8.931800E-01
Normal-vs-Occasional Drinker
9.483000E-01
Normal-vs-Social Drinker
8.855600E-01
Non Drinker-vs-Daily Drinker
8.085800E-01
Non Drinker-vs-Weekly Drinker
4.889000E-01
Non Drinker-vs-Occasional Drinker
5.383800E-01
Non Drinker-vs-Social Drinker
4.613400E-01
Daily Drinker-vs-Weekly Drinker
4.593800E-01
Daily Drinker-vs-Occasional Drinker
4.709800E-01
Daily Drinker-vs-Social Drinker
4.253200E-01
Weekly Drinker-vs-Occasional Drinker
8.387000E-01
Weekly Drinker-vs-Social Drinker
9.605400E-01
Occasional Drinker-vs-Social Drinker
8.568400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.747000E-01
Normal-vs-Grade 2
2.743800E-01
Normal-vs-Grade 3
1.597230E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.053800E-02
Grade 1-vs-Grade 3
1.607500E-02
Grade 1-vs-Grade 4
6.747000E-01
Grade 2-vs-Grade 3
1.827790E-01
Grade 2-vs-Grade 4
2.743800E-01
Grade 3-vs-Grade 4
1.597230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.078600E-01
Normal-vs-NonDiabetic
8.446400E-01
Diabetic-vs-NonDiabetic
8.738400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.318600E-01
Normal-vs-NoPancreatitis
9.273000E-01
Pancreatitis-vs-NoPancreatitis
5.103600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.258400E-01
Normal-vs-N1
9.038600E-01
N0-vs-N1
2.298000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.287600E-01
Normal-vs-TP53-NonMutant
8.714200E-01
TP53-Mutant-vs-TP53-NonMutant
8.786200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
